Harvard Catalyst Profiles

Contact, publication, and social network information about Harvard faculty and fellows.

Catherine Belle Meador, M.D.

Concepts (122)

Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Lung Neoplasms202024132491.240 Why?
Drug Resistance, Neoplasm11202452300.950 Why?
Small Cell Lung Carcinoma720244210.910 Why?
Thoracic Neoplasms120232650.720 Why?
Carcinoma, Non-Small-Cell Lung5202352480.700 Why?
Leadership2201613720.550 Why?
Molecular Targeted Therapy3202028050.500 Why?
Genotype32021129590.500 Why?
Protein Kinase Inhibitors6202156400.500 Why?
Antineoplastic Agents62021136290.450 Why?
Mutation122024299510.360 Why?
Biomedical Research2201634210.360 Why?
MAP Kinase Signaling System2201514830.320 Why?
Proto-Oncogene Proteins B-raf2201520520.300 Why?
Acrylamides320172600.250 Why?
Neoplasms42023220660.240 Why?
Negotiating220161480.240 Why?
Education, Medical, Graduate1201623590.230 Why?
Education, Medical1201617280.230 Why?
Exodeoxyribonucleases120241950.220 Why?
Epigenomics220249360.190 Why?
Aniline Compounds3201710680.190 Why?
Career Choice220167550.170 Why?
Gene Amplification1202410850.170 Why?
Paraneoplastic Syndromes, Nervous System12019240.170 Why?
Biology120212890.170 Why?
Tumor Microenvironment3202438290.160 Why?
Genetic Variation1201465400.160 Why?
Quinazolines2201513630.160 Why?
Cardiology Service, Hospital120192420.150 Why?
Mice, Nude4201736050.140 Why?
Focal Adhesion Protein-Tyrosine Kinases120171860.140 Why?
Receptor, EphA212016410.130 Why?
Phosphoproteins1202424410.130 Why?
Exons1202123910.130 Why?
Colorectal Neoplasms1201568560.120 Why?
src-Family Kinases120175340.120 Why?
Group Processes120162260.120 Why?
Humans2620247602760.110 Why?
Cell Line, Tumor72024169080.110 Why?
Niacinamide120164140.110 Why?
Lymphocytes, Tumor-Infiltrating1201910900.110 Why?
Professional Competence120164310.100 Why?
Curriculum2201637220.100 Why?
INDEL Mutation120132660.100 Why?
Patient Admission1201913840.100 Why?
Cell Lineage1202025250.090 Why?
Cell Transformation, Neoplastic2202428230.090 Why?
Benzamides1201613700.090 Why?
DNA, Neoplasm1201517450.090 Why?
Xenograft Model Antitumor Assays3202435840.080 Why?
Animals1120241679350.080 Why?
Academic Medical Centers1201927530.080 Why?
Antineoplastic Combined Chemotherapy Protocols32017117080.070 Why?
Receptor Protein-Tyrosine Kinases1201416140.070 Why?
Piperazines1201725200.070 Why?
Protein-Tyrosine Kinases1201524150.070 Why?
Sensitivity and Specificity12021146550.060 Why?
Genome, Human2201544160.060 Why?
Octamer Transcription Factors12023180.060 Why?
Healthcare Disparities1201933800.060 Why?
Mice82024812120.050 Why?
Biopsy1201567750.050 Why?
Lactates120234040.050 Why?
Cell Proliferation22016104390.050 Why?
Neoplasm Recurrence, Local2201792740.050 Why?
Health Services Accessibility1201953950.050 Why?
Genetic Testing1201435330.050 Why?
Chemokines120249620.040 Why?
Proto-Oncogene Proteins c-myc120249950.040 Why?
Treatment Outcome32020649680.040 Why?
Genomics1201457900.040 Why?
Adenocarcinoma1201563100.040 Why?
Gene Expression Regulation, Neoplastic2202485020.040 Why?
Basic Helix-Loop-Helix Transcription Factors1202311370.040 Why?
Pneumonectomy1202311100.030 Why?
Melanoma1201456940.030 Why?
Heart Failure12019118360.030 Why?
Chemotherapy, Adjuvant1202335310.030 Why?
Survival Rate22019128060.030 Why?
Drug Screening Assays, Antitumor120157170.030 Why?
Immunity, Innate1202430460.030 Why?
Aged420191690020.020 Why?
Drug Synergism1201617550.020 Why?
Combined Modality Therapy1202385510.020 Why?
Epigenesis, Genetic1202437580.020 Why?
CD8-Positive T-Lymphocytes1202445540.020 Why?
DNA Methylation1202443740.020 Why?
Drug Evaluation, Preclinical1201513450.020 Why?
Benzimidazoles120158580.020 Why?
ras Proteins1201510510.020 Why?
Male520243594270.020 Why?
Transfection1201757820.020 Why?
Signal Transduction32017233660.020 Why?
Neoplasm Staging12023111410.020 Why?
Macrophages1202357460.020 Why?
Immunotherapy1202446370.020 Why?
Health Status Disparities1201918200.020 Why?
Inpatients1201925800.020 Why?
Retrospective Studies32023803110.020 Why?
Proto-Oncogene Proteins p21(ras)1201517290.020 Why?
Boston1201992830.020 Why?
Patient Readmission1201933290.020 Why?
Drug Therapy, Combination1201564990.020 Why?
Lung1202399880.020 Why?
DNA Copy Number Variations1201320110.010 Why?
Female520243910240.010 Why?
Transcription Factors12023121000.010 Why?
Aged, 80 and over22019589530.010 Why?
Sequence Analysis, DNA1201347170.010 Why?
Longitudinal Studies12017144810.010 Why?
High-Throughput Nucleotide Sequencing1201336180.010 Why?
Middle Aged320192201790.010 Why?
Apoptosis1201694970.010 Why?
Prognosis12019296400.010 Why?
Risk Assessment12019240860.010 Why?
Time Factors12019401410.010 Why?
Follow-Up Studies12017392560.010 Why?
Polymorphism, Single Nucleotide12013157650.010 Why?
Prospective Studies12017542650.010 Why?
Risk Factors12019742780.010 Why?
Adult120172198430.000 Why?
Meador's Networks
Click the
Explore
buttons for more information and interactive visualizations!
Concepts (122)
Explore
_
Co-Authors (111)
Explore
_
Similar People (60)
Explore
_
Same Department 
Explore
_
Funded by the NIH National Center for Advancing Translational Sciences through its Clinical and Translational Science Awards Program, grant number UL1TR002541.